The USD/SGD hovered near 1.30085 on Thursday as markets remained calm following the U.S. government’s reopening, with sentiment cautiously leaning bearish.
An improved outlook, a year-over-year decline in earnings per share, contracting margins, and rising medical costs create an engaging narrative for UnitedHealth Group. Should you buy the sell-off?